| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.2 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.2 |